Bank Julius Baer & Co’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03K | Buy |
40
+5
| +14% | +$629 | ﹤0.01% | 593 |
|
|
2025
Q1 | $5.47K | Sell |
35
-1
| -3% | -$156 | ﹤0.01% | 590 |
|
|
2024
Q4 | $6.1K | Buy |
36
+2
| +6% | +$339 | ﹤0.01% | 611 |
|
|
2024
Q3 | $7.73K | Sell |
34
-819
| -96% | -$186K | ﹤0.01% | 499 |
|
|
2024
Q2 | $220K | Sell |
853
-1,155
| -58% | -$298K | ﹤0.01% | 341 |
|
|
2024
Q1 | $433K | Buy |
2,008
+296
| +17% | +$63.8K | ﹤0.01% | 325 |
|
|
2023
Q4 | $443K | Buy |
1,712
+53
| +3% | +$13.7K | ﹤0.01% | 337 |
|
|
2023
Q3 | $426K | Sell |
1,659
-421
| -20% | -$108K | ﹤0.01% | 334 |
|
|
2023
Q2 | $592K | Buy |
2,080
+903
| +77% | +$257K | ﹤0.01% | 318 |
|
|
2023
Q1 | $327K | Sell |
1,177
-998
| -46% | -$277K | ﹤0.01% | 387 |
|
|
2022
Q4 | $602K | Buy |
2,175
+34
| +2% | +$9.41K | ﹤0.01% | 325 |
|
|
2022
Q3 | $572K | Buy |
2,141
+214
| +11% | +$57.2K | ﹤0.01% | 322 |
|
|
2022
Q2 | $393K | Sell |
1,927
-150
| -7% | -$30.6K | ﹤0.01% | 359 |
|
|
2022
Q1 | $437K | Sell |
2,077
-250
| -11% | -$52.6K | ﹤0.01% | 357 |
|
|
2021
Q4 | $558K | Sell |
2,327
-398
| -15% | -$95.4K | ﹤0.01% | 413 |
|
|
2021
Q3 | $771K | Sell |
2,725
-1,979
| -42% | -$560K | ﹤0.01% | 364 |
|
|
2021
Q2 | $1.63M | Sell |
4,704
-56,987
| -92% | -$19.7M | 0.01% | 305 |
|
|
2021
Q1 | $17.3M | Sell |
61,691
-3,910
| -6% | -$1.09M | 0.13% | 122 |
|
|
2020
Q4 | $16.1M | Sell |
65,601
-32,194
| -33% | -$7.88M | 0.13% | 114 |
|
|
2020
Q3 | $27.7M | Sell |
97,795
-13,176
| -12% | -$3.74M | 0.27% | 75 |
|
|
2020
Q2 | $29.6M | Sell |
110,971
-10,090
| -8% | -$2.69M | 0.34% | 67 |
|
|
2020
Q1 | $38.3M | Buy |
+121,061
| New | +$38.3M | 0.89% | 32 |
|